Stem Cells for Drug Discovery & Toxicity Screening 2017

Date: Monday, 10 July 2017 - Tuesday, 11 July 2017
Location: Boston, USA

Moderator

Emma Sceats
Chief Executive Officer, CN Bio Innovations Ltd.

Keynote Speakers

Linda Griffith
Professor, Massachusetts Institute of Technology (MIT)

Michael Shuler
Samuel B. Eckert Professor of Engineering, Cornell University, President Hesperos, Inc.

Norio Nakatsuji
Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University

Gary Gintant
Senior Research Fellow, Abbvie

Devyn Smith
Chief Operating Officer, Sigilon

Roger Kamm
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT)

John Wikswo
Gordon A. Cain University Professor, A.B. Learned Professor of Living State Physics; Founding Director, Vanderbilt Institute for Integrative Biosystems, Vanderbilt University

Katia Karalis
Executive Vice President of Research, Emulate, Inc.

Tommy Andersson
Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, AstraZeneca, Gothenburg

Ksenia Blinova
Senior Technical Manager, Induced Pluripotent Stem Cell and Electrophysiology Core Facility, Center for Devices and Radiological Health (CDRH), US Food and Drug Administration (FDA)

Overview

Select Biosciences, Inc. Stem Cells in Drug Discovery & Toxicity Screening 2017 is held concurrently with the Select Biosciences, Inc. Third Annual Organ-on-a-Chip World Congress 2017 focuses on an important and expanding field wherein cells are being assembled using Microfluidics and Lab-on-a-Chip technologies in a functionally-relevant manner. These clusters of "assembled cells" have functional significance and can mimic in vivo organ structure.

Liver cells assembled on-board chips in a physiologically-relevant architecture using microfluidics can, for instance, be utilized for toxicity screening and the ability to assemble organ fragments ex vivo can provide an exquisite means to reconstruct biological processes (both physiological and pathological) "in a dish" or "on a chip." A number of chips such Lung-on-a-Chip, Brain-on-a-Chip, Gut-on-a-Chip, Marrow-on-a-Chip, Bone-on-a-Chip, Nerve-on-a-Chip amongst others have been built and will be presented and explored at this conference. We will also focus on "disease-on-a-chip", cancer-on-a-chip, immune system-on-a-chip and toxicity screening-on-a-chip.

The Three Conference Tracks are Co-Located and Concurrent and Delegates can Participate, Mix-and-Match Presentations and Network Extensively with their Colleagues from all 3 Conference Tracks.

Co-Located, Concurrent Conference Tracks:
Organ-on-a-Chip World Congress 2017
3D-Culture 2017
Stem Cells in Drug Discovery & Toxicity Screening 2017
All the Key Opinion Leaders from around the World are Participating at this Conference allowing Maximal Information Exchange and Unparalleled Networking Opportunities.

Session Sponsors

Agenda Topics

iPSC-derived Cells for Toxicity Testing & Screening
Screening Technologies, Instrumentation and Reagents
Stem Cells in Drug Discovery and Development
Use of Microfluidics Organs-on-Chips for Toxicity Screening

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Mark Bradley, Professor of Therapeutic Innovation, Precision Healthcare University Research Institute, Queen Mary University of London
Ulrich Broeckel, Professor of Pediatrics, Medicine and Physiology - Chief, Section of Genomic Pediatrics, Medical College of Wisconsin
Stephen Crocker, Associate Professor, Department of Neuroscience, University of Connecticut School of Medicine
Guohao Dai, Associate Professor, Department of Bioengineering, Northeastern University
Toshihiko Ezashi, Research Associate Professor, The University of Missouri
Robert Halliwell, Professor of Neuroscience, University of The Pacific
Katharina Kuenzel, Researcher, FAU Erlangen-Nuremberg, Institute of Medical Biotechnology
Daman Kumari, Staff Scientist, Laboratory of Cell and Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH)
Greg Luerman, Technical Director, Axiogenesis AG
Zhen Ma, Assistant Professor, Samuel and Carol Nappi Research Scholar, Syracuse Biomaterials Institute, Syracuse University
Siobhan Malany, Director, Translational Biology, Sanford Burnham Prebys Medical Discovery Institute
Ryuji Morizane, Associate Biologist, Renal Division, Brigham and Women’s Hospital Affiliated Faculty, Harvard Stem Cell Institute
Bikash Pattnaik, M. D. Matthews Professor, McPherson Eye Research Institute, University of Wisconsin, Madison
Bonnie Quach, Researcher, Weill Cornell Graduate School
Ikuro Suzuki, Associate Professor, Tohoku Institute of Technology
Huan Wang, Research Fellow, Department of Systems Biology, Harvard Medical School, Harvard Therapeutic Science Program
Matthew White, ORISE Fellow, US FDA National Center for Toxicological Research
Xianmin Zeng, Associate Professor, Buck Institute for Research on Aging
Daniele Zink, Principal Research Scientist and Team Leader, Institute of Bioengineering and Nanotechology, Agency for Science Technology and Research (A*STAR)

Corporate Sponsors	Media Sponsors	Official Journal Partner	Networking

Add to Calendar ▼2017-07-10 00:00:002017-07-11 00:00:00Europe/LondonStem Cells for Drug Discovery and Toxicity Screening 2017Stem Cells for Drug Discovery and Toxicity Screening 2017 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors